Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$236,289
+$59,253 QoQ
Shares Held
939
+15.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#3,832
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 9%
Shared 32%
None 59%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advantage Trust Co holds $1,835,316 across 10 Drug Manufacturers - General names. ABBV ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
865 | $1,037,507 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
939 | $236,289 | |
| 3 | JNJ |
Johnson & Johnson
|
786 | $199,620 | |
| 4 | PFE |
Pfizer Inc
|
5,353 | $128,900 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,700 | $97,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
709 | $91,106 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
138 | $17,434 | |
| 8 | GSK |
GSK plc
|
240 | $12,580 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $236,289 | 939 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $177,036 | 814 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $185,990 | 814 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $269,512 | 1,164 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $308,871 | 1,664 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $352,622 | 1,683 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $303,689 | 1,709 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $364,153 | 1,844 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $316,282 | 1,844 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $335,791 | 1,844 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $285,763 | 1,844 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||